Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Barnstable Brown Diabetes Center - Diabetes and Obesity Research Day

Image of pipette

SAVE THE DATE

10th Annual Barnstable Brown Diabetes and Obesity Research Series
Virtual Seminar Series November 2, 3, 11, 18 2021

Each year, researchers from the University of Kentucky and other regional institutes share their current findings and ongoing research about the alarming rise in obesity and diabetes rates at the Barnstable Brown Diabetes Center – Diabetes and Obesity Research Day.

Presenters also discuss prevention and treatment of these epidemic-level diseases.

  • 2021 Speakers

    Nichole Danielle Allred, PhD

    allredDr. Nicole Danielle Allred is an Associate Professor of Biochemistry at Wake Forest School of Medicine.

    Date: November 2, 2021, 12 - 1:30 p.m.

    Nichole Allred, PhD, is a molecular biologist with a research focus of understanding the genetic architecture of complex diseases and underlying risk factors in minority populations. With an emphasis on metabolic disease, her research focuses on type 2 diabetes, nephropathy, obesity, liver disease and cardiovascular disease (CVD). She was awarded a K99/R00 Pathway to Independence award, which advanced her expertise in the areas of high-throughput genotyping technologies and quantitative intermediate phenotype analysis and interpretation. Her lab integrates a wide range of genetic, transcriptomic, metabolomic and bioinformatic approaches to understand disease pathophysiology. To provide broader context to the research findings, Allred is involved in multiple large-scale collaborative projects.


    Jonathan R. Brestoff, MD, PhD, MPH

    brestoff

    Dr. Jonathan R. Brestoff is Assistant Professor, Pathology & Immunology at Washington University School of Medicine in St. Louis.

    Date: November 3, 2021, 3 - 4:30 p.m.

    Jonathan R. Brestoff, MD, PhD, MPH is a physician-scientist interested in understanding how the immune system and endocrine organs interact to regulate metabolic homeostasis and the pathogenesis of obesity and type 2 diabetes. He received his MD and PhD from the Perelman School of Medicine at the University of Pennsylvania, where he worked with Dr. David Artis to study how Interleukin (IL)-33 and Group 2 innate lymphoid cells (ILC2s) regulate beige fat function and the development of obesity. He then completed residency in Clinical Pathology at Washington University School of Medicine (WashU) and Barnes-Jewish Hospital, working with Dr. Steven Teitelbaum before starting his independent laboratory at WashU as a recipient of the NIH Director’s Early Independence Award (DP5) and Burroughs Wellcome Fund Career Award for Medical Scientists. The Brestoff Lab continues to study immunometabolism and how immune cells and adipocytes interact to regulate local and systemic metabolism.


    Kristina Utzschneider, MD

    kristinaDr. Kristina Utzschneider is an Associate Professor in the Medicine Division of Metabolism, Endocrinology and Nutrition at University of Washington.

    Date: November 11, 2021, 3 - 4:30 p.m.

    Kristina Utzschneider, MD, is a board-certified physician at the VA Puget Sound, director of the VA Diabetes Care Program and a UW associate professor of Medicine and Metabolism, Endocrinology and Nutrition. She earned her medical degree . from Harvard and completed residency and fellowship at the University of Washington. She is a clinical researcher focused on the pathogenesis, treatment and prevention of type 2 diabetes. Her research has explored the effects of medications and diet on liver fat, insulin sensitivity and beta-cell function.


    Kevan Herold, MD

    heroldDr. Kevan Herold is C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology) at Yale School of Medicine.

    Date: November 18, 2021, 3 - 4:30 p.m.

    Kevan Herold, MD, is a researcher in translational immunology. He is interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. His focus has largely been in the field of autoimmune type 1 diabetes. His work encompasses basic laboratory work and clinical studies to understand the regulation of autoreactive T cells as well as clinical trials that involve novel therapeutics. As part of these studies, he is interested in analysis of beta cell function in type 1 diabetes,  studying the development of autoimmune diabetes in patients with cancers who are treated with checkpoint inhibitors. His lab’s clinical and basic studies are focused on understanding how beta cells are destroyed and react to inflammation. With the COVID-19 pandemic, he and his colleagues have been studying the immunologic basis for responses in children and adults who are hospitalized with COVID-19 to understand the mechanisms that can lead to disease protection.

  • 2021 Sponsors

    • UK Barnstable Brown Diabetes Center
    • The Center of Research in Obesity and Cardiovascular Disease – (P30GM127211) from the National Institute of General Medical Sciences (NIGMS)
    • University of Kentucky Department of Pharmacology & Nutritional Sciences